PCM
PLXP

Prelude Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Prelude Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56,052
Closed -$1.08M – 2356
2021
Q3 		$1.08M Buy
+56,052
New +$980K 0.03% 536
2015
Q3 		– Sell
-125
Closed -$13K – 1881
2015
Q2 		$13K Sell
125
-280
-69% -$29K ﹤0.01% 1535
2015
Q1 		$44K Buy
+405
New +$41.5K 0.01% 1373

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Prelude Capital Management's PLXP Position: Q4 2021 in Review

Prelude Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2021, closing a stake of 56,052 shares — an estimated $1.08M sold.

Prelude Capital Management first reported a position in PLXP in Q1 2015 and held it in 3 quarters. The position peaked at $1.08M in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • Prelude Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Prelude Capital Management sold 56,052 PLx Pharma Inc. Common Stock shares in Q4 2021, an estimated $1.08M.
  • Prelude Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Prelude Capital Management's PLx Pharma Inc. Common Stock position peaked at $1.08M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on Prelude Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.